Aurobindo Pharma share price falls 6.46% today, stock among top losers on Nifty Midcap 150

Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

At previous close, the Sensex was up 485.35 points (0.58 percent) at 84,065.75, and the Nifty was up 173.60 points (0.68 percent) at 25,867.3

Shares of Aurobindo Pharma declined 6.46% to Rs 1,125.90, making it one of the top losers on the Nifty Midcap 150 on Tuesday. KPR Mill, Hind Zinc, Bharti Hexacom and NHPC were also among the top losers on the index at 2:30 pm.

Aurobindo Pharma Limited - Financial Overview

Aurobindo Pharma Limited's revenue and net profit have shown considerable fluctuations over the past few years. The consolidated revenue for the year ending March 2025 stood at Rs 31,723.73 Crore, compared to Rs 29,001.87 Crore in the previous year. The net profit for the same period was Rs 3,515.26 Crore, up from Rs 3,186.13 Crore in March 2024.

Quarterly Performance:

The quarterly revenue saw a rise from Rs 7,978.52 Crore in December 2024 to Rs 8,645.90 Crore in December 2025. During the same period, net profit increased from Rs 843.98 Crore to Rs 909.43 Crore.

Here is a detailed look at the company's consolidated financial performance:

Corporate Actions

Aurobindo Pharma Limited has announced an investor presentation. The company's board meeting outcome on February 9, 2026, indicated details regarding company performance and strategies. Furthermore, the US FDA inspection at Unit III of Eugia Pharma Specialities Ltd., a wholly-owned subsidiary, has been completed.

Dividend History:

Aurobindo Pharma has a history of consistent dividend payouts. The company announced an interim dividend of Rs 4 in August 2025. The dividend data shows a mix of interim and final dividends, reflecting a commitment to returning value to shareholders.

The company announced a split where old FV was 5 and new FV was 1 on Feb 10, 2011.

Aurobindo Pharm shares were among the top losers on the Nifty Midcap 150 at 2:30 pm.